Close

BIND Therapeutics (BIND) Appoints Andrew Hirsch as Permanent CEO

June 22, 2015 10:17 AM EDT Send to a Friend
BIND Therapeutics (Nasdaq: BIND) announced that Andrew Hirsch has been appointed president and chief executive officer of the Company. Mr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login